Abstract No 666 will detail the IHC assay development that is being used to support the investigation of the relevance of #PI3Kδ expression in #solidtumours in our ongoing first-in-human #clinicaltrial (NCT04328844).
Abstract No 5660 will describe the characterisation of novel #CD73 antibodies and the selection of a candidate for further development.
Abstracts are available to view on the iOnctura website:
And on the AACR website: https://bit.ly/2LCrEBl and https://bit.ly/367OdY0
#AACR #cancer